Edinburgh Research Explorer

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

Research output: Contribution to journalArticle

  • Donavan T Cheng
  • Deog Kyeom Kim
  • Debra A Cockayne
  • Anton Belousov
  • Hans Bitter
  • Michael H Cho
  • Annelyse Duvoix
  • Lisa D Edwards
  • David A Lomas
  • Bruce E Miller
  • Niki Reynaert
  • Ruth Tal-Singer
  • Emiel F M Wouters
  • Alvar Agustí
  • Leonardo M Fabbri
  • Alex Rames
  • Sudha Visvanathan
  • Stephen I Rennard
  • Paul Jones
  • Harsukh Parmar
  • William MacNee
  • Gerhard Wolff
  • Edwin K Silverman
  • Ruth J Mayer
  • Sreekumar G Pillai
  • TESRA and ECLIPSE Investigators

Related Edinburgh Organisations

Original languageEnglish
Pages (from-to)948-57
Number of pages10
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume188
Issue number8
DOIs
Publication statusPublished - 15 Oct 2013

Abstract

Emphysema in chronic obstructive pulmonary disease (COPD) can be characterized by high-resolution chest computed tomography (HRCT); however, the repeated use of HRCT is limited because of concerns regarding radiation exposure and cost.

    Research areas

  • Aged, Biological Markers, Emphysema, Female, Humans, Lung, Male, Middle Aged, Polymorphism, Single Nucleotide, Pulmonary Disease, Chronic Obstructive, Receptors, Immunologic, Severity of Illness Index, Tomography, Spiral Computed

ID: 15016544